{"mainPropery":{"diseaseId":2788,"diseaseName":"Hyper-IgD syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/2788/hyper-igd-syndrome","synonyms":["Hyper IgD syndrome","Hyperimmunoglobulinemia D and periodic fever syndrome","Periodic fever Dutch type","HIDS"],"synonyms-with-source":[{"name":"Hyper IgD syndrome"},{"name":"Hyperimmunoglobulinemia D and periodic fever syndrome"},{"name":"Periodic fever Dutch type"},{"name":"HIDS","source":""}],"identifiers":[{"identifierType":"OMIM","identifierId":"260920"},{"identifierType":"ORPHANET","identifierId":"343"},{"identifierType":"UMLS","identifierId":"C0398691"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":13,"diseaseTypeName":"Immune System Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":15,"diseaseTypeName":"Musculoskeletal Diseases","source":"Orphanet"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":3600,"resourceName":"FMF & AID Global Association","abbreviation":"","address1":"Schüracherstrasse 25a","address2":"8306 Brüttisellen","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Switzerland","phone":"+41 76 415 4010","tty":"","tollFree":"","fax":"","email":"info@fmfandaid.org ","url":"https://www.fmfandaid.org/","freeText":""},{"resourceID":4166,"resourceName":"Rare Autoinflammatory Conditions Community - UK","abbreviation":"RACC-UK","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"07377091552","tty":"","tollFree":"","fax":"","email":"info@raccuk.com","url":"https://www.raccuk.com/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/260920' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=hyper%20IgD%20syndrome%5Bti%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Hyper-IgD syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://clinicaltrials.gov/ct2/results?term=hyper-IgD' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Hyper-IgD syndrome. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":825,"resourceId":1499,"resourceName":"Hyper IgD syndrome","descriptionText":"The <a href='http://www.thedoctorsdoctor.com/diseases/hyper_igd_syndrome.htm ' target='_blank'>Doctor's Doctor</a> provides information about hyper IgD syndrome. Click on the link to view this information.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":879,"resourceId":1585,"resourceName":"RDCRN - Steroid and Isoprenoid Research Consortium (STAIR)","descriptionText":"The <a href='https://www.rarediseasesnetwork.org/cms/stair/' target='_blank'>Sterol and Isoprenoid Diseases Consortium (STAIR)</a> is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with this condition through research. The Steroid and Isoprenoid Research Consortium (STAIR) has a registry for patients who wish to be contacted about clinical research opportunities. <br /><br />For more information on the registry see: <a href='https://www.rarediseasesnetwork.org/cms/stair/Get-Involved/ContactRegistry' target='_blank'>https://www.rarediseasesnetwork.org/cms/stair/Get-Involved/ContactRegistry</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1169/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/952254-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=343' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://dermnetnz.org/systemic/hyper-igd.html' target='_blank'>DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1700,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The&nbsp;<a href='https://www.merckmanuals.com/professional/pediatrics/hereditary-periodic-fever-syndromes/hyper-igd-syndrome' target='_blank'>Merck Manual</a> for health care professionals provides information on&nbsp;Hyper-IgD syndrome.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1707,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"The&nbsp;<a href='http://www.ojrd.com/content/1/1/13' target='_blank'>Orphanet Journal of Rare Diseases</a> has published an article with information on this condition.&nbsp;This journal is&nbsp;affiliated with the <a href=\"http://www.orpha.net/\" target=\"_blank\">Orphanet</a>&nbsp;reference portal for information on rare diseases and orphan drugs.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:260920' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":3171,"questionText":"What is hyper IgD syndrome?","answerText":"<strong>Hyper IgD syndrome</strong> is the less severe form of a metabolic disorder known as <a href=\"https://ghr.nlm.nih.gov/condition/mevalonate-kinase-deficiency#resources\" target=\"_blank\">mevalonate kinase deficiency</a>. It is considered an auto-inflammatory disease, with <span> recurrent episodic or chronic unexplained inflammation,</span>&nbsp;characterized by periodic episodes of fever, and other symptoms such as joint pain, swollen lymph nodes, skin rash, headaches, and abdominal pain. Most episodes last several days and occur periodically throughout life. The frequency of episodes and their severity vary greatly from person to person.[2161][13523] These attacks can occur spontaneously or be triggered by vaccinations, infections, and/or emotional or physical stress. Growth and development is usually not affected. Hyper IgD syndrome&nbsp;is caused by mutations in the <a href=\"https://ghr.nlm.nih.gov/gene/MVK\"><span aria-label=\"M V K\"><em>MVK</em></span></a> gene which provides instructions for making the mevalonate kinase enzyme.&nbsp;The mutations result in the partial deficiency of the enzyme. A more severe form of maevalonate kinase deficiency is known as <a href=\"https://rarediseases.info.nih.gov/diseases/3588/mevalonic-aciduria\" target=\"_blank\">mevalonic aciduria</a>.[2162][2163]&nbsp;It is inherited&nbsp;in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[2161][2163] Treatment is with&nbsp;<a href=\"https://medlineplus.gov/druginfo/meds/a602001.html\" target=\"_blank\">anakinra</a>, and other medications,&nbsp;<span>but not all patients show a complete response. In most cases, the frequency of the disease's episodes decreases over time.[13523]&nbsp;</span>","dateModified":"2017-06-26T00:00:00"},"basicQuestions":[{"questionId":3172,"questionText":"What are the signs and symptoms of hyper IgD syndrome?","answerText":"Hyper IgD syndrome is characterized by periodic&nbsp;high fevers that may be associated with other symptoms including:[2162][2164][13523]<br />\r\n<ul>\r\n    <li>Cold chills</li>\r\n    <li>Swollen lymph nodes (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003097.htm\" target=\"_blank\" style=\"font-size: 12pt;\">lymphadenopathy</a><span style=\"font-size: 12pt;\">)</span></li>\r\n    <li>Abdominal pain</li>\r\n    <li>Diarrhea</li>\r\n    <li>Headache</li>\r\n    <li>Joints pain</li>\r\n    <li>Increased size of the liver (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003275.htm\" target=\"_blank\" style=\"font-size: 12pt;\">hepatomegaly</a><span style=\"font-size: 12pt;\">) and/or increased size of the spleen (</span><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003276.htm\" target=\"_blank\" style=\"font-size: 12pt;\">splenomegaly</a><span style=\"font-size: 12pt;\">)</span></li>\r\n    <li>Skin lesions</li>\r\n    <li>Canker sores (<a href=\"https://medlineplus.gov/cankersores.html\" target=\"_blank\">aphthous ulcers</a>)</li>\r\n</ul>\r\nMost episodes last several days and occur periodically throughout life.[2161] The frequency of episodes and their severity vary greatly from person to person.[2161][2162] The first attack usually takes place during infancy.[2164]&nbsp;Patients may have no symptoms between attacks. However, in some patients, the attacks may be so frequent that the symptoms persist.[2162]&nbsp;The attacks can occur spontaneously or be triggered by vaccinations, infections, and/or emotional or physical stress. Growth and development is usually not affected.[2164][2161] Disease complications sometimes seen in adults include <a href=\"https://medlineplus.gov/amyloidosis.html\" target=\"_blank\">amyloidosis</a>, abdominal <a href=\"https://medlineplus.gov/adhesions.html\" target=\"_blank\">adhesions</a>, and very rarely joint <a href=\"https://medlineplus.gov/ency/article/003185.htm\" target=\"_blank\">contractures</a>.[2164] <br />\r\n<br />\r\nSome people seem to have an intermediate form that is more severe than hyper IgD syndrome but less severe than classic mevalonate aciduria. These people suffer from a neurological illness with or without periodic fever.[13523]","dateModified":"2017-06-26T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":2161,"authors":"","articleTitle":"Hyper IgD Syndrome","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2017","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1169/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2162,"authors":"Shinawi M, Scaglia F","articleTitle":"Hereditary Periodic Fever Syndromes","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/952254-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2164,"authors":"Frenkel J, Simon A","articleTitle":"Hyperimmunoglobulinemia D with recurrent fever","bookWebsiteJournalTitle":"Orphanet","date":"2011","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=343","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13523,"authors":"Jos W M & van der Meer AS","articleTitle":"The challenge of autoinflammatory syndromes with an emphasis on hyper-IgD syndrome","bookWebsiteJournalTitle":"Rheumatology","date":"2016","volume":"55(2)","pages":"23-29","url":"https://www.ncbi.nlm.nih.gov/pubmed/27856657","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3173,"questionText":"What causes hyper IgD syndrome?","answerText":"Hyper IgD syndrome is caused by mutations in the gene <em><a href=\"https://ghr.nlm.nih.gov/gene/MVK\" target=\"_blank\">MVK</a>&nbsp;</em>which<em>&nbsp;</em>encodes the enzyme mevalonate kinase. The mutations lead to a partial deficiency of the enzyme mevalonate kinase.[2162][2164]&nbsp;This enzyme converts a substance called mevalonic acid into mevalonate-5-phosphate. This conversion is the second step in a <a href=\"http://themedicalbiochemistrypage.org/cholesterol.php#synthesis\" target=\"_blank\">pathway that makes cholesterol</a>. The cholesterol is later converted into steroid hormones and bile acids. Steroid hormones are needed for normal development and reproduction, and bile acids are used to digest fats. The enzyme also helps to produce other substances that are necessary for certain cellular functions, such as cell growth, cell maturation (differentiation), formation of the cell's structural framework (the cytoskeleton), gene activity (expression), and protein production and modification.&nbsp;A role for this pathway in inflammation is still not completely understood, but it is known that the mevalonate pathway produces cholesterol, and also some compounds which are necessary for the proper interaction and function of these proteins.[13524]","dateModified":"2017-06-26T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":2162,"authors":"Shinawi M, Scaglia F","articleTitle":"Hereditary Periodic Fever Syndromes","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/952254-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2164,"authors":"Frenkel J, Simon A","articleTitle":"Hyperimmunoglobulinemia D with recurrent fever","bookWebsiteJournalTitle":"Orphanet","date":"2011","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=343","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13524,"authors":"Sönmez HE & Özen S","articleTitle":"A clinical update on inflammasomopathies","bookWebsiteJournalTitle":"Int Immunol","date":"April 6, 2017","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/28387826","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3174,"questionText":"Is hyper IgD syndrome inherited?","answerText":"Hyper IgD syndrome&nbsp;is inherited&nbsp;in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner, which means both copies of the gene in each cell have mutations. The parents of a person with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.[2161][2164]","dateModified":"2017-06-27T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":2161,"authors":"","articleTitle":"Hyper IgD Syndrome","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2017","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1169/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2162,"authors":"Shinawi M, Scaglia F","articleTitle":"Hereditary Periodic Fever Syndromes","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/952254-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2164,"authors":"Frenkel J, Simon A","articleTitle":"Hyperimmunoglobulinemia D with recurrent fever","bookWebsiteJournalTitle":"Orphanet","date":"2011","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=343","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3175,"questionText":"How might hyper IgD syndrome be treated?","answerText":"The mainstay of the treatment of hyper IgD is anakinra, but not all patients show a complete response.  Usually five to seven daily injections are sufficient to prevent an early relapse. Anakinra can also be used to prevent vaccine-induced attacks in patients that need immunizations.[13524]\r\n<p><span>In 2015, a group of experts from different countries proposed recommendations for the management of several anti-inflammatory diseases including hyper IgD syndrome. Recommendations include:[13525]<br />\r\n</span></p>\r\n<ul>\r\n    <li><a href=\"http://www.nsaidslist.com/\" target=\"_blank\">NSAIDs</a> may provide symptom relief during inflammatory attacks</li>\r\n    <li>Short-term glucocorticoids, with or without NSAIDs, may be effective for alleviating inflammatory attacks</li>\r\n    <li>Short-term IL-1 blocking agents (anakinra&nbsp; or canakinumab) may be effective for ending inflammatory attacks and should be considered to limit or prevent steroid side effects or as a maintenance therapy </li>\r\n    <li>If one IL-1-blocking agent at an adequate dose is ineffective or not well tolerated, a switch to another IL-1-blocking agent or another biological agent (including <a href=\"https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm109340.htm\" target=\"_blank\">TNF-&alpha; blockers</a>&nbsp;(etanercept (Enbrel),&nbsp; rituximab, o infliximab) &nbsp;or IL-6 blockade (tocilizumab) should be considered. </li>\r\n    <li>If TNF-&alpha; blocker is ineffective or intolerable, a switch to another biological agent (including an IL-1- or IL-6-blocking agent) should be considered.</li>\r\n</ul>\r\n<p><span> In selected cases with severe disease that does not improve, and poor quality of life, referral to a specialist center for consideration of <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=270732\" target=\"_blank\">allogeneic hematopoietic stem cell transplantation</a> is recommended.[13525]<br />\r\n<br />\r\nConsultations with the following specialists may be helpful: dermatologist, rheumatologist, and infectious disease specialist (to evaluate periodic fever).[2162]&nbsp;</span></p>","dateModified":"2017-06-26T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":2162,"authors":"Shinawi M, Scaglia F","articleTitle":"Hereditary Periodic Fever Syndromes","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/952254-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2164,"authors":"Frenkel J, Simon A","articleTitle":"Hyperimmunoglobulinemia D with recurrent fever","bookWebsiteJournalTitle":"Orphanet","date":"2011","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=343","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13525,"authors":"Ozen S & Demir S","articleTitle":"Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient","bookWebsiteJournalTitle":"Paediatr Drugs","date":"May 11, 2017","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/28497352","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3176,"questionText":"What is the prognosis for individuals with hyper IgD syndrome?","answerText":"Life expectancy is not shortened except for in rare cases where severe infections or kidney&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/amyloidosis.html\" target=\"_blank\">amyloidosis</a>&nbsp;occur. Between fever attacks, patients are&nbsp;generally free of symptoms. Attacks do continue throughout the lifetime, although there may be a slight decrease following adolescence.[2162] <span>A long-term follow-up study  showed that the frequency of the attacks decreases over time, but about half of the patients more than 20 years of age still experience six or more attacks per year, with quite an impact on quality of life.[13524]</span>","dateModified":"2017-06-26T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":2162,"authors":"Shinawi M, Scaglia F","articleTitle":"Hereditary Periodic Fever Syndromes","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/952254-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13524,"authors":"Sönmez HE & Özen S","articleTitle":"A clinical update on inflammasomopathies","bookWebsiteJournalTitle":"Int Immunol","date":"April 6, 2017","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/28387826","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":31986,"abbreviatedInquiry":"Are&nbsp;there certain foods that can trigger a flare up of hyper IgD syndrome?&nbsp;","caseQuestions":[{"questionId":5146,"questionText":"Are there&nbsp;any foods that&nbsp;are known to&nbsp;trigger attacks in individuals with&nbsp;hyper IgD syndrome?","answerText":"A search of the resources available to us did not identify any reports&nbsp;of&nbsp;foods that have been&nbsp;found to cause&nbsp;attacks in individuals with&nbsp;hyper IgD syndrome. We encourage you to discuss any specific factors which appear to trigger attacks in your particular case with your health care provider(s).<br>","dateModified":"2011-08-25T17:06:00","references":[]},{"questionId":5145,"questionText":"What factors may precipitate attacks in individuals with hyper IgD syndrome?","answerText":"Fever episodes in individuals with&nbsp;hyper IgD syndrome&nbsp;can be triggered by vaccinations, surgery, injury, or stress.[2162][4175] ","dateModified":"2013-03-05T15:57:00","references":[{"referenceId":2162,"authors":"Shinawi M, Scaglia F","articleTitle":"Hereditary Periodic Fever Syndromes","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/952254-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":4175,"authors":"","articleTitle":"Mevalonate kinase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2011","url":"http://ghr.nlm.nih.gov/condition/mevalonate-kinase-deficiency","dateAccessed":"2013-03-05T00:00:00"}]}]},{"caseId":25849,"abbreviatedInquiry":"Can you please provide me with general information about hyper IgD syndrome?","caseQuestions":[{"questionId":3171,"questionText":"What is hyper IgD syndrome?","answerText":"<strong>Hyper IgD syndrome</strong> is the less severe form of a metabolic disorder known as <a href=\"https://ghr.nlm.nih.gov/condition/mevalonate-kinase-deficiency#resources\" target=\"_blank\">mevalonate kinase deficiency</a>. It is considered an auto-inflammatory disease, with <span> recurrent episodic or chronic unexplained inflammation,</span>&nbsp;characterized by periodic episodes of fever, and other symptoms such as joint pain, swollen lymph nodes, skin rash, headaches, and abdominal pain. Most episodes last several days and occur periodically throughout life. The frequency of episodes and their severity vary greatly from person to person.[2161][13523] These attacks can occur spontaneously or be triggered by vaccinations, infections, and/or emotional or physical stress. Growth and development is usually not affected. Hyper IgD syndrome&nbsp;is caused by mutations in the <a href=\"https://ghr.nlm.nih.gov/gene/MVK\"><span aria-label=\"M V K\"><em>MVK</em></span></a> gene which provides instructions for making the mevalonate kinase enzyme.&nbsp;The mutations result in the partial deficiency of the enzyme. A more severe form of maevalonate kinase deficiency is known as <a href=\"https://rarediseases.info.nih.gov/diseases/3588/mevalonic-aciduria\" target=\"_blank\">mevalonic aciduria</a>.[2162][2163]&nbsp;It is inherited&nbsp;in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[2161][2163] Treatment is with&nbsp;<a href=\"https://medlineplus.gov/druginfo/meds/a602001.html\" target=\"_blank\">anakinra</a>, and other medications,&nbsp;<span>but not all patients show a complete response. In most cases, the frequency of the disease's episodes decreases over time.[13523]&nbsp;</span>","dateModified":"2017-06-26T00:00:00","references":[{"referenceId":2161,"authors":"","articleTitle":"Hyper IgD Syndrome","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2017","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1169/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2162,"authors":"Shinawi M, Scaglia F","articleTitle":"Hereditary Periodic Fever Syndromes","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/952254-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2163,"authors":"","articleTitle":"Hyper-IgD Syndrome","bookWebsiteJournalTitle":"Online Mendelian Inheritance in Man (OMIM)","date":"2013","volume":"","pages":"","url":"http://omim.org/entry/260920","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13523,"authors":"Jos W M & van der Meer AS","articleTitle":"The challenge of autoinflammatory syndromes with an emphasis on hyper-IgD syndrome","bookWebsiteJournalTitle":"Rheumatology","date":"2016","volume":"55(2)","pages":"23-29","url":"https://www.ncbi.nlm.nih.gov/pubmed/27856657","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3172,"questionText":"What are the signs and symptoms of hyper IgD syndrome?","answerText":"Hyper IgD syndrome is characterized by periodic&nbsp;high fevers that may be associated with other symptoms including:[2162][2164][13523]<br />\r\n<ul>\r\n    <li>Cold chills</li>\r\n    <li>Swollen lymph nodes (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003097.htm\" target=\"_blank\" style=\"font-size: 12pt;\">lymphadenopathy</a><span style=\"font-size: 12pt;\">)</span></li>\r\n    <li>Abdominal pain</li>\r\n    <li>Diarrhea</li>\r\n    <li>Headache</li>\r\n    <li>Joints pain</li>\r\n    <li>Increased size of the liver (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003275.htm\" target=\"_blank\" style=\"font-size: 12pt;\">hepatomegaly</a><span style=\"font-size: 12pt;\">) and/or increased size of the spleen (</span><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003276.htm\" target=\"_blank\" style=\"font-size: 12pt;\">splenomegaly</a><span style=\"font-size: 12pt;\">)</span></li>\r\n    <li>Skin lesions</li>\r\n    <li>Canker sores (<a href=\"https://medlineplus.gov/cankersores.html\" target=\"_blank\">aphthous ulcers</a>)</li>\r\n</ul>\r\nMost episodes last several days and occur periodically throughout life.[2161] The frequency of episodes and their severity vary greatly from person to person.[2161][2162] The first attack usually takes place during infancy.[2164]&nbsp;Patients may have no symptoms between attacks. However, in some patients, the attacks may be so frequent that the symptoms persist.[2162]&nbsp;The attacks can occur spontaneously or be triggered by vaccinations, infections, and/or emotional or physical stress. Growth and development is usually not affected.[2164][2161] Disease complications sometimes seen in adults include <a href=\"https://medlineplus.gov/amyloidosis.html\" target=\"_blank\">amyloidosis</a>, abdominal <a href=\"https://medlineplus.gov/adhesions.html\" target=\"_blank\">adhesions</a>, and very rarely joint <a href=\"https://medlineplus.gov/ency/article/003185.htm\" target=\"_blank\">contractures</a>.[2164] <br />\r\n<br />\r\nSome people seem to have an intermediate form that is more severe than hyper IgD syndrome but less severe than classic mevalonate aciduria. These people suffer from a neurological illness with or without periodic fever.[13523]","dateModified":"2017-06-26T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":2161,"authors":"","articleTitle":"Hyper IgD Syndrome","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2017","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1169/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2162,"authors":"Shinawi M, Scaglia F","articleTitle":"Hereditary Periodic Fever Syndromes","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/952254-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2164,"authors":"Frenkel J, Simon A","articleTitle":"Hyperimmunoglobulinemia D with recurrent fever","bookWebsiteJournalTitle":"Orphanet","date":"2011","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=343","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13523,"authors":"Jos W M & van der Meer AS","articleTitle":"The challenge of autoinflammatory syndromes with an emphasis on hyper-IgD syndrome","bookWebsiteJournalTitle":"Rheumatology","date":"2016","volume":"55(2)","pages":"23-29","url":"https://www.ncbi.nlm.nih.gov/pubmed/27856657","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3173,"questionText":"What causes hyper IgD syndrome?","answerText":"Hyper IgD syndrome is caused by mutations in the gene <em><a href=\"https://ghr.nlm.nih.gov/gene/MVK\" target=\"_blank\">MVK</a>&nbsp;</em>which<em>&nbsp;</em>encodes the enzyme mevalonate kinase. The mutations lead to a partial deficiency of the enzyme mevalonate kinase.[2162][2164]&nbsp;This enzyme converts a substance called mevalonic acid into mevalonate-5-phosphate. This conversion is the second step in a <a href=\"http://themedicalbiochemistrypage.org/cholesterol.php#synthesis\" target=\"_blank\">pathway that makes cholesterol</a>. The cholesterol is later converted into steroid hormones and bile acids. Steroid hormones are needed for normal development and reproduction, and bile acids are used to digest fats. The enzyme also helps to produce other substances that are necessary for certain cellular functions, such as cell growth, cell maturation (differentiation), formation of the cell's structural framework (the cytoskeleton), gene activity (expression), and protein production and modification.&nbsp;A role for this pathway in inflammation is still not completely understood, but it is known that the mevalonate pathway produces cholesterol, and also some compounds which are necessary for the proper interaction and function of these proteins.[13524]","dateModified":"2017-06-26T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":2162,"authors":"Shinawi M, Scaglia F","articleTitle":"Hereditary Periodic Fever Syndromes","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/952254-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2164,"authors":"Frenkel J, Simon A","articleTitle":"Hyperimmunoglobulinemia D with recurrent fever","bookWebsiteJournalTitle":"Orphanet","date":"2011","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=343","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13524,"authors":"Sönmez HE & Özen S","articleTitle":"A clinical update on inflammasomopathies","bookWebsiteJournalTitle":"Int Immunol","date":"April 6, 2017","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/28387826","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3174,"questionText":"Is hyper IgD syndrome inherited?","answerText":"Hyper IgD syndrome&nbsp;is inherited&nbsp;in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner, which means both copies of the gene in each cell have mutations. The parents of a person with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.[2161][2164]","dateModified":"2017-06-27T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":2161,"authors":"","articleTitle":"Hyper IgD Syndrome","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2017","volume":"","pages":"","url":"http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1169/viewAbstract","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2162,"authors":"Shinawi M, Scaglia F","articleTitle":"Hereditary Periodic Fever Syndromes","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/952254-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2164,"authors":"Frenkel J, Simon A","articleTitle":"Hyperimmunoglobulinemia D with recurrent fever","bookWebsiteJournalTitle":"Orphanet","date":"2011","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=343","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3175,"questionText":"How might hyper IgD syndrome be treated?","answerText":"The mainstay of the treatment of hyper IgD is anakinra, but not all patients show a complete response.  Usually five to seven daily injections are sufficient to prevent an early relapse. Anakinra can also be used to prevent vaccine-induced attacks in patients that need immunizations.[13524]\r\n<p><span>In 2015, a group of experts from different countries proposed recommendations for the management of several anti-inflammatory diseases including hyper IgD syndrome. Recommendations include:[13525]<br />\r\n</span></p>\r\n<ul>\r\n    <li><a href=\"http://www.nsaidslist.com/\" target=\"_blank\">NSAIDs</a> may provide symptom relief during inflammatory attacks</li>\r\n    <li>Short-term glucocorticoids, with or without NSAIDs, may be effective for alleviating inflammatory attacks</li>\r\n    <li>Short-term IL-1 blocking agents (anakinra&nbsp; or canakinumab) may be effective for ending inflammatory attacks and should be considered to limit or prevent steroid side effects or as a maintenance therapy </li>\r\n    <li>If one IL-1-blocking agent at an adequate dose is ineffective or not well tolerated, a switch to another IL-1-blocking agent or another biological agent (including <a href=\"https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm109340.htm\" target=\"_blank\">TNF-&alpha; blockers</a>&nbsp;(etanercept (Enbrel),&nbsp; rituximab, o infliximab) &nbsp;or IL-6 blockade (tocilizumab) should be considered. </li>\r\n    <li>If TNF-&alpha; blocker is ineffective or intolerable, a switch to another biological agent (including an IL-1- or IL-6-blocking agent) should be considered.</li>\r\n</ul>\r\n<p><span> In selected cases with severe disease that does not improve, and poor quality of life, referral to a specialist center for consideration of <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=270732\" target=\"_blank\">allogeneic hematopoietic stem cell transplantation</a> is recommended.[13525]<br />\r\n<br />\r\nConsultations with the following specialists may be helpful: dermatologist, rheumatologist, and infectious disease specialist (to evaluate periodic fever).[2162]&nbsp;</span></p>","dateModified":"2017-06-26T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":2162,"authors":"Shinawi M, Scaglia F","articleTitle":"Hereditary Periodic Fever Syndromes","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/952254-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2164,"authors":"Frenkel J, Simon A","articleTitle":"Hyperimmunoglobulinemia D with recurrent fever","bookWebsiteJournalTitle":"Orphanet","date":"2011","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=343","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13525,"authors":"Ozen S & Demir S","articleTitle":"Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient","bookWebsiteJournalTitle":"Paediatr Drugs","date":"May 11, 2017","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/28497352","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3176,"questionText":"What is the prognosis for individuals with hyper IgD syndrome?","answerText":"Life expectancy is not shortened except for in rare cases where severe infections or kidney&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/amyloidosis.html\" target=\"_blank\">amyloidosis</a>&nbsp;occur. Between fever attacks, patients are&nbsp;generally free of symptoms. Attacks do continue throughout the lifetime, although there may be a slight decrease following adolescence.[2162] <span>A long-term follow-up study  showed that the frequency of the attacks decreases over time, but about half of the patients more than 20 years of age still experience six or more attacks per year, with quite an impact on quality of life.[13524]</span>","dateModified":"2017-06-26T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":2162,"authors":"Shinawi M, Scaglia F","articleTitle":"Hereditary Periodic Fever Syndromes","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/952254-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13524,"authors":"Sönmez HE & Özen S","articleTitle":"A clinical update on inflammasomopathies","bookWebsiteJournalTitle":"Int Immunol","date":"April 6, 2017","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/28387826","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13419,"phenoTypeName":"Abdominal pain","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":7919,"phenoTypeName":"Arthralgia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":6246,"phenoTypeName":"Elevated erythrocyte sedimentation rate","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8110,"phenoTypeName":"Gastrointestinal hemorrhage","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10948,"phenoTypeName":"Increased circulating IgA level","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13313,"phenoTypeName":"Lymphadenopathy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3980,"phenoTypeName":"Myalgia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13054,"phenoTypeName":"Recurrent fever","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5670,"phenoTypeName":"Arthritis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13709,"phenoTypeName":"Migraine","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":957,"phenoTypeName":"Papule","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":317,"phenoTypeName":"Recurrent aphthous stomatitis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8303,"phenoTypeName":"Urticaria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13800,"phenoTypeName":"Vasculitis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9329,"phenoTypeName":"Acrocyanosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11167,"phenoTypeName":"Erythema","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4082,"phenoTypeName":"Growth delay","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13532,"phenoTypeName":"Intestinal obstruction","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5675,"phenoTypeName":"Limitation of joint mobility","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13764,"phenoTypeName":"Peritonitis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8268,"phenoTypeName":"Purpura","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5620,"phenoTypeName":"Rod-cone dystrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5374,"phenoTypeName":"Chills","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13420,"phenoTypeName":"Chronic diarrhea","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4931,"phenoTypeName":"Chronic oral candidiasis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13033,"phenoTypeName":"Elevated urine mevalonic acid","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11446,"phenoTypeName":"Febrile seizure (within the age range of 3 months to 6 years)","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11409,"phenoTypeName":"Headache","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8125,"phenoTypeName":"Hepatosplenomegaly","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11543,"phenoTypeName":"Increased circulating IgD level","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6245,"phenoTypeName":"Infantile onset","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":7929,"phenoTypeName":"Lymphadenitis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":3334,"phenoTypeName":"Molluscum contagiosum","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9751,"phenoTypeName":"Oral ulcer","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":12116,"phenoTypeName":"Renal angiomyolipoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":380,"phenoTypeName":"Serositis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8270,"phenoTypeName":"Skin rash","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13400,"phenoTypeName":"Vomiting","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":13075,"phenoTypeName":"Leukocytosis","percentRanges":"-"},{"phenoTypeId":1545,"phenoTypeName":"Neutrophilia","percentRanges":"-"},{"phenoTypeId":10138,"phenoTypeName":"Nyctalopia","percentRanges":"-"},{"phenoTypeId":5651,"phenoTypeName":"Optic disc pallor","percentRanges":"-"},{"phenoTypeId":11411,"phenoTypeName":"Vertigo","percentRanges":"-"}],"medicalProducts":[{"productId":651,"genericName":"Canakinumab","tradeName":"Ilaris","tradeLink":"http://www.ilaris.com/index.jsp","manufacturer":"","sponsor":"Novartis Pharmaceuticals Corporation","indication":"Treatment for Familial Mediterranean Fever (FMF) in adult and pediatric patients; for Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS) in adult and pediatric patients; and for Hyperimmunoglobulin D Syndrome (HIDS)/Mevalonate Kinase Deficiency (MKD) in adult and pediatric patients.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/ilaris","medlinePlusLink":""}],"EncodedName":"Hyper-IgD_syndrome"}